|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| 2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
| 2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
Avivagen Inc. reported earnings results for the full year ended October 31, 2022. For the full year, the company reported sales was CAD 0.939173 million compared to CAD 1.3 million a year ago. Net loss was CAD 6.07 million compared to CAD 6.39 million a year ago.
Basic loss per share from continuing operations was CAD 0.09 compared to CAD 0.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 283K | |
| +11.04% | 11.42B | |
| -4.29% | 5.57B | |
| -0.50% | 4.94B | |
| +3.57% | 4.58B | |
| -21.31% | 2.66B | |
| -22.67% | 1.14B | |
| -20.67% | 918M | |
| +28.84% | 913M | |
| -16.12% | 891M |
AVIVAGEN INC. 
